SHANE BURKETT: Open Payments
NPI 1750926010 · LOYSBURG, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,169 in 116 payments from 22 companies in 2025. Trend: 2023 $2,587 · 2024 $2,644 · 2025 $2,169
Food & beverage: $2,148Education: $20
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 16 | $342 |
| Lilly USA, LLC | 15 | $256 |
| AstraZeneca Pharmaceuticals LP | 13 | $250 |
| PFIZER INC. | 13 | $190 |
| ABBVIE INC. | 8 | $139 |
| Amgen Inc. | 9 | $135 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $99 |
| Paratek Pharmaceuticals, Inc. | 5 | $93 |
| Verona Pharma, Inc. | 3 | $93 |
| GlaxoSmithKline, LLC. | 4 | $80 |
Products named: Ozempic, JARDIANCE, MOUNJARO, NURTEC ODT, FARXIGA, TEZSPIRE, Ohtuvayre, REPATHA.
Industry payments across PA — which companies pay providers there.
